Your institution may have access to this item. Find your institution then sign in to continue.
Title
Can Europe accelerate out of trouble?
Abstract
The author reflects on the uncertainty of the biotechnological market in Europe. It was found that the biotech companies in the continent is not developing compared to the bioengineering industry in the neighboring countries. In comparison, the growth is slow in European biotech firms due to the lesser access to the centralized management, low grade facilities and a low budget for the business.